(TACT) TransAct Technologies - Ratings and Ratios
Thermal Printers, POS Terminals, Consumables, Replacement Parts, Software
TACT EPS (Earnings per Share)
TACT Revenue
Description: TACT TransAct Technologies
TransAct Technologies Incorporated is a specialized manufacturer of printers and terminals for transaction-based and niche applications, operating globally with a focus on the United States. The companys product portfolio includes thermal printers and terminals that produce labels, coupons, and transaction records, such as receipts and tickets. Additionally, it offers a range of consumable products, including POS receipt paper and printing supplies, as well as maintenance and repair services for its devices.
The companys product ecosystem is complemented by software solutions like EPICENTRAL, a print system designed for casino operators to create and print promotional coupons and marketing messages directly at slot machines. This is a testament to its commitment to providing comprehensive solutions for its clients, particularly in the casino and gaming markets. Furthermore, TransActs BOHA! terminal, which integrates hardware and software components, showcases its innovative approach to transaction-based technologies.
TransAct Technologies markets its products under several brands, catering to diverse sectors such as food service technology, point of sale automation, and casino and gaming. Its distribution strategy includes selling to original equipment manufacturers, value-added resellers, and distributors, as well as directly to end-users through its online store, transactsupplies.com. This multifaceted approach allows the company to maintain a broad market presence.
Analyzing the provided
Forecasting based on the available data, if TACT can stabilize its SMA20 and SMA50 while moving towards its SMA200, it may indicate a recovery trajectory. However, the high forward P/E ratio and negative RoE are concerning. A potential forecast could be that if the company can turn its RoE positive and maintain a stable or increasing stock price, it might attract more investors, potentially driving the stock price towards the 52W High of $4.93. Conversely, failure to address the current negative RoE could lead to further decline, potentially testing the 52W Low of $3.27. Thus, a cautious approach is warranted, closely monitoring the companys financial health and market trends.
TACT Stock Overview
| Market Cap in USD | 40m |
| Sub-Industry | Technology Hardware, Storage & Peripherals |
| IPO / Inception | 1996-08-22 |
TACT Stock Ratings
| Growth Rating | -48.4 |
| Fundamental | 30.5% |
| Dividend Rating | 13.4 |
| Rel. Strength | -24.3 |
| Analysts | 4.00 of 5 |
| Fair Price Momentum | 3.80 USD |
| Fair Price DCF | 1.34 USD |
TACT Dividends
Currently no dividends paidTACT Growth Ratios
| Growth Correlation 3m | 43.6% |
| Growth Correlation 12m | -73% |
| Growth Correlation 5y | -71.9% |
| CAGR 5y | -5.83% |
| CAGR/Max DD 5y | -0.07 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -20.55 |
| Beta | 0.558 |
| Volatility | 41.21% |
| Current Volume | 19.2k |
| Average Volume 20d | 19.2k |
| Stop Loss | 3.8 (-6.4%) |
| Signal | -0.84 |
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-8.63m TTM) > 0 and > 6% of Revenue (6% = 2.88m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 55.90% (prev 49.86%; Δ 6.04pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 3.19m > Net Income -8.63m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (10.1m) change vs 12m ago 0.67% (target <= -2.0% for YES) |
| Gross Margin 47.47% (prev 50.78%; Δ -3.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.0% (prev 104.7%; Δ -3.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -20.94 (EBITDA TTM -1.03m / Interest Expense TTM 85.0k) >= 6 (WARN >= 3) |
Altman Z'' 4.37
| (A) 0.60 = (Total Current Assets 39.7m - Total Current Liabilities 12.9m) / Total Assets 44.5m |
| (B) 0.10 = Retained Earnings (Balance) 4.39m / Total Assets 44.5m |
| (C) -0.04 = EBIT TTM -1.78m / Avg Total Assets 47.5m |
| (D) 0.34 = Book Value of Equity 4.53m / Total Liabilities 13.3m |
| Total Rating: 4.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 30.46
| 1. Piotroski 1.50pt = -3.50 |
| 2. FCF Yield 11.29% = 5.0 |
| 3. FCF Margin 6.18% = 1.55 |
| 4. Debt/Equity 0.13 = 2.49 |
| 5. Debt/Ebitda -3.94 = -2.50 |
| 6. ROIC - WACC -12.41% = -12.50 |
| 7. RoE -26.31% = -2.50 |
| 8. Rev. Trend -74.15% = -3.71 |
| 9. Rev. CAGR -8.23% = -1.37 |
| 10. EPS Trend data missing |
| 11. EPS CAGR -31.36% = -2.50 |
What is the price of TACT shares?
Over the past week, the price has changed by +2.53%, over one month by +13.09%, over three months by +16.00% and over the past year by -8.76%.
Is TransAct Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TACT is around 3.80 USD . This means that TACT is currently overvalued and has a potential downside of -6.4%.
Is TACT a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TACT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5 | 23.2% |
| Analysts Target Price | 5 | 23.2% |
| ValueRay Target Price | 4.2 | 3.4% |
Last update: 2025-08-11 02:06
TACT Fundamental Data Overview
CCE Cash And Equivalents = 17.7m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 47.3934
P/S = 0.8726
P/B = 1.276
P/EG = 0.91
Beta = 1.266
Revenue TTM = 47.9m USD
EBIT TTM = -1.78m USD
EBITDA TTM = -1.03m USD
Long Term Debt = 379.0k USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 3.70m USD (from shortTermDebt, last quarter)
Debt = 4.08m USD (Calculated: Short Term 3.70m + Long Term 379.0k)
Net Debt = -14.0m USD (from netDebt column, last quarter)
Enterprise Value = 26.3m USD (39.9m + Debt 4.08m - CCE 17.7m)
Interest Coverage Ratio = -20.94 (Ebit TTM -1.78m / Interest Expense TTM 85.0k)
FCF Yield = 11.29% (FCF TTM 2.96m / Enterprise Value 26.3m)
FCF Margin = 6.18% (FCF TTM 2.96m / Revenue TTM 47.9m)
Net Margin = -18.00% (Net Income TTM -8.63m / Revenue TTM 47.9m)
Gross Margin = 47.47% ((Revenue TTM 47.9m - Cost of Revenue TTM 25.2m) / Revenue TTM)
Tobins Q-Ratio = 5.79 (Enterprise Value 26.3m / Book Value Of Equity 4.53m)
Interest Expense / Debt = 2.08% (Interest Expense 85.0k / Debt 4.08m)
Taxrate = 21.0% (US default)
NOPAT = -1.78m (EBIT -1.78m, no tax applied on loss)
Current Ratio = 3.08 (Total Current Assets 39.7m / Total Current Liabilities 12.9m)
Debt / Equity = 0.13 (Debt 4.08m / last Quarter total Stockholder Equity 31.3m)
Debt / EBITDA = -3.94 (Net Debt -14.0m / EBITDA -1.03m)
Debt / FCF = 1.38 (Debt 4.08m / FCF TTM 2.96m)
Total Stockholder Equity = 32.8m (last 4 quarters mean)
RoA = -19.38% (Net Income -8.63m, Total Assets 44.5m )
RoE = -26.31% (Net Income TTM -8.63m / Total Stockholder Equity 32.8m)
RoCE = -5.36% (Ebit -1.78m / (Equity 32.8m + L.T.Debt 379.0k))
RoIC = -4.94% (NOPAT -1.78m / Invested Capital 36.1m)
WACC = 7.47% (E(39.9m)/V(44.0m) * Re(8.07%)) + (D(4.08m)/V(44.0m) * Rd(2.08%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.43%
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 66.61% ; FCFE base≈3.44m ; Y1≈1.94m ; Y5≈654.1k
Fair Price DCF = 1.34 (DCF Value 13.5m / Shares Outstanding 10.1m; 5y FCF grow -50.0% → 3.0% )
Revenue Correlation: -74.15 | Revenue CAGR: -8.23%
Revenue Growth Correlation: 51.99%
EPS Correlation: N/A | EPS CAGR: -31.36%
EPS Growth Correlation: 24.31%
Additional Sources for TACT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle